Multifunctional antibody responses from a primate Shigella outbreak inform vaccine design
Science Translational Medicine · 2026
DOI: 10.1126/scitranslmed.aef7084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, 2026. Verfasst von Robert M Gallant und 19 weiteren Autor:innen. Beteiligte Einrichtung: IAVI Neutralizing Antibody Center, San Diego, CA, USA. Hauptthemen laut MEDLINE: Shigella Vaccines, Dysentery, Bacillary, Disease Outbreaks, Antibody Formation. Die Arbeit nennt 105 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, NCRR NIH HHS, NIH HHS.
Abstract (Originalsprache)
There is currently no approved vaccine for Shigella spp., a leading cause of diarrhea with increasing rates of antimicrobial resistance. Shigella vaccine development is complicated in part by an incomplete understanding of the structural and molecular determinants of immunity. To address this, we isolated monoclonal antibodies against candidate Shigella vaccine antigens using samples from a Shigella flexneri outbreak in a nonhuman primate (NHP) research facility. We found that antibodies targeting the Shigella O-antigen can undergo substantial affinity maturation (>10%) to acquire broad cross-reactivity across S. flexneri serotypes. We also found that the virulence-associated type III secretion system (T3SS) proteins IpaD and IpaB elicit moderate T cell and robust antibody responses. T3SS antibodies could either inhibit or enhance bacterial virulence in vitro and differed in vivo depending on their epitope specificity. Collectively, these findings provide insights into protective and deleterious immune responses against Shigella that directly inform vaccine immunogen design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- IAVI Neutralizing Antibody Center, San Diego, CA, USA.
- Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
- Bond Life Sciences Center and Department of Veterinary Pathobiology, University of Missouri, Columbia, MO, USA.
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, USA.
- Department of Medicine, Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.
- UW Veterinary Care, University of Wisconsin-Madison, Madison, WI, USA.
ORCID-Profile: Robert M Gallant, Paul Savarino, Sophia Pulido, Morgan S A Gilman, Ti Lu, Jennifer Hayes, Nicholas L Xerri, Mark A Ochoa, Zackary Dietz, Eric Peterson, Timothy Scott, Faye Hartmann, Stephen G Baker, Devin Sok, Andrew C Kruse, Wendy Picking, Saverio V Capuano, Hayden R Schmidt
Förderung
- Wellcome Trust
- NCRR NIH HHS
- NIH HHS
- National Institutes of Health
- Wellcome
Zitieren
APA
Gallant, R. M., Savarino, P., Pulido, S., Gilman, M. S. A., Lu, T., Hayes, J., Xerri, N. L., Williams, T., Ochoa, M. A., Dietz, Z., Peterson, E., Scott, T., Hartmann, F., Baker, S. G., Kaminski, R. W., Sok, D., Kruse, A. C., Picking, W., Capuano, S. V., & Schmidt, H. R. (2026). Multifunctional antibody responses from a primate Shigella outbreak inform vaccine design. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aef7084
Vancouver
Gallant RM, Savarino P, Pulido S, Gilman MSA, Lu T, Hayes J, et al. Multifunctional antibody responses from a primate Shigella outbreak inform vaccine design. Science Translational Medicine. 2026. doi:10.1126/scitranslmed.aef7084
BibTeX
@article{Gallant2026,
author = {Gallant, Robert M and Savarino, Paul and Pulido, Sophia and Gilman, Morgan S A and Lu, Ti and Hayes, Jennifer and Xerri, Nicholas L and Williams, Torrey and Ochoa, Mark A and Dietz, Zackary and Peterson, Eric and Scott, Timothy and Hartmann, Faye and Baker, Stephen G and Kaminski, Robert W and Sok, Devin and Kruse, Andrew C and Picking, Wendy and Capuano, Saverio V and Schmidt, Hayden R},
title = {Multifunctional antibody responses from a primate Shigella outbreak inform vaccine design},
journal = {Science Translational Medicine},
year = {2026},
doi = {10.1126/scitranslmed.aef7084}
}
EUVIMED